In distinguishing AD from bvFTD both pTau181 and GFAP retained prominence, yielding an AUC of 0.90 (95%CI = 0.79–1.00) and 0.87 (95%CI = 0.76–0.98), respectively. This evidence concerns the gene GFAP and Alzheimer disease.